FdaApplication
ANDA 207825
Identifiers
- fda_app_no: ANDA207825
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING LLC |
| application_type | ANDA |
| approval_date | 2020-07-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE | DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE | 10MG;10MG | TABLET, DELAYED RELEASE;ORAL |
1 product